Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.

Arnedo M, Taffé P, Sahli R, Furrer H, Hirschel B, Elzi L, Weber R, Vernazza P, Bernasconi E, Darioli R, Bergmann S, Beckmann JS, Telenti A, Tarr PE; Swiss HIV Cohort Study..

Pharmacogenet Genomics. 2007 Sep;17(9):755-64.

PMID:
17700364
2.

Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.

Tarr PE, Taffé P, Bleiber G, Furrer H, Rotger M, Martinez R, Hirschel B, Battegay M, Weber R, Vernazza P, Bernasconi E, Darioli R, Rickenbach M, Ledergerber B, Telenti A; Swiss HIV Cohort Study..

J Infect Dis. 2005 May 1;191(9):1419-26. Epub 2005 Mar 22. Erratum in: J Infect Dis. 2005 Jun 1;191(11):1997.

PMID:
15809899
3.

Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.

Rotger M, Bayard C, Taffé P, Martinez R, Cavassini M, Bernasconi E, Battegay M, Hirschel B, Furrer H, Witteck A, Weber R, Ledergerber B, Telenti A, Tarr PE; Swiss HIV Cohort Study..

Circ Cardiovasc Genet. 2009 Dec;2(6):621-8. doi: 10.1161/CIRCGENETICS.109.874412. Epub 2009 Sep 18.

4.

APOE, CETP and LPL genes show strong association with lipid levels in Greek children.

Smart MC, Dedoussis G, Louizou E, Yannakoulia M, Drenos F, Papoutsakis C, Maniatis N, Humphries SE, Talmud PJ.

Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):26-33. doi: 10.1016/j.numecd.2009.02.005. Epub 2009 Apr 28.

5.

Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.

Stancáková A, Baldaufová L, Javorský M, Kozárová M, Salagovic J, Tkác I.

Physiol Res. 2006;55(5):483-90. Epub 2005 Dec 12.

6.

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.

Guardiola M, Echeverria P, González M, Vallvé JC, Puig J, Clotet B, Ribalta J, Negredo E.

AIDS Res Hum Retroviruses. 2015 Sep;31(9):882-8. doi: 10.1089/AID.2015.0061. Epub 2015 Jul 20.

PMID:
26101956
7.

Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.

Lamon-Fava S, Asztalos BF, Howard TD, Reboussin DM, Horvath KV, Schaefer EJ, Herrington DM.

Clin Endocrinol (Oxf). 2010 Feb;72(2):169-75. doi: 10.1111/j.1365-2265.2009.03644.x. Epub 2009 May 29.

8.

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.

Egaña-Gorroño L, Martínez E, Cormand B, Escribà T, Gatell J, Arnedo M.

AIDS. 2013 Feb 20;27(4):529-38. doi: 10.1097/QAD.0b013e32835d0da1.

PMID:
23262498
9.

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients.

Echeverria P, Guardiola M, González M, Vallvé JC, Bonjoch A, Puig J, Clotet B, Ribalta J, Negredo E.

Antiviral Res. 2015 Feb;114:48-52. doi: 10.1016/j.antiviral.2014.12.002. Epub 2014 Dec 8.

PMID:
25500319
10.

Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.

Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B.

Pharmacogenomics J. 2008 Jun;8(3):228-36. Epub 2007 Aug 28.

PMID:
17726453
11.

Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.

Brito DD, Fernandes AP, Gomes KB, Coelho FF, Cruz NG, Sabino AP, Cardoso JE, Figueiredo-Filho PP, Diamante R, Norton CR, Sousa MO.

Mol Biol Rep. 2011 Oct;38(7):4381-8. doi: 10.1007/s11033-010-0565-5. Epub 2010 Dec 4.

PMID:
21132386
13.

Prediction of genetic risk for dyslipidemia.

Yamada Y, Matsuo H, Warita S, Watanabe S, Kato K, Oguri M, Yokoi K, Metoki N, Yoshida H, Satoh K, Ichihara S, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Nozawa Y.

Genomics. 2007 Nov;90(5):551-8. Epub 2007 Oct 4.

14.

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.

Tarr PE, Rotger M, Telenti A.

Pharmacogenomics. 2010 Apr;11(4):587-94. doi: 10.2217/pgs.10.35. Review.

PMID:
20350140
15.

Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).

Raj R, Bhatti JS, Badada SK, Ramteke PW.

Diabetes Metab Res Rev. 2015 Oct;31(7):663-71. doi: 10.1002/dmrr.2630. Epub 2015 Mar 5. Review.

PMID:
25470794
16.

Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.

Komurcu-Bayrak E, Onat A, Poda M, Humphries SE, Palmen J, Guclu F, Can G, Erginel-Unaltuna N.

Clin Chem Lab Med. 2008;46(6):778-84. doi: 10.1515/CCLM.2008.161.

PMID:
18601598
17.

Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.

Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kivimaki M, Whittaker J, Humphries SE, Hingorani AD; ASCOT investigators.; NORDIL investigators.; BRIGHT Consortium..

Am J Hum Genet. 2009 Nov;85(5):628-42. doi: 10.1016/j.ajhg.2009.10.014.

18.

Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.

Xiao Z, Wang J, Chen W, Wang P, Zeng H, Chen W.

Lipids Health Dis. 2012 Nov 26;11:163. doi: 10.1186/1476-511X-11-163.

19.

Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels.

Villard EF, EI Khoury P, Frisdal E, Bruckert E, Clement K, Bonnefont-Rousselot D, Bittar R, Le Goff W, Guerin M.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):822-8. doi: 10.1161/ATVBAHA.112.300979. Epub 2013 Jan 31.

20.

Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants.

Klos KL, Sing CF, Boerwinkle E, Hamon SC, Rea TJ, Clark A, Fornage M, Hixson JE.

Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1828-36. Epub 2006 Jun 8.

Supplemental Content

Support Center